These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24574825)

  • 41. Extended-release ranolazine: critical evaluation of its use in stable angina.
    Truffa AA; Newby LK; Melloni C
    Vasc Health Risk Manag; 2011; 7():535-9. PubMed ID: 21915171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
    Kosiborod M; Arnold SV; Spertus JA; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Katz A; Jones PG; Olmsted A; Belardinelli L; Chaitman BR
    J Am Coll Cardiol; 2013 May; 61(20):2038-45. PubMed ID: 23500237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Re-thinking angina.
    Conti CR
    Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I1-3. PubMed ID: 18373324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ranolazine: a review of its use in chronic stable angina pectoris.
    Keating GM
    Drugs; 2008; 68(17):2483-503. PubMed ID: 19016575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranolazine: a review of its use in chronic stable angina pectoris.
    Siddiqui MA; Keam SJ
    Drugs; 2006; 66(5):693-710. PubMed ID: 16620147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ranolazine as a First-Choice Anti-anginal Medication for Patients With Coronary Artery Ectasia: A Case Series.
    Ahmed JA; Ahmed KA; Ahmed MH
    Cureus; 2024 Jan; 16(1):e52747. PubMed ID: 38384654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
    Chaitman BR; Skettino SL; Parker JO; Hanley P; Meluzin J; Kuch J; Pepine CJ; Wang W; Nelson JJ; Hebert DA; Wolff AA;
    J Am Coll Cardiol; 2004 Apr; 43(8):1375-82. PubMed ID: 15093870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spotlight on ranolazine in chronic stable angina pectoris.
    Siddiqui MA; Keam SJ
    Am J Cardiovasc Drugs; 2006; 6(5):357-9. PubMed ID: 17083271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
    Gutierrez JA; Karwatowska-Prokopczuk E; Murphy SA; Belardinelli L; Farzaneh-Far R; Walker G; Morrow DA; Scirica BM
    Clin Cardiol; 2015 Aug; 38(8):469-75. PubMed ID: 26059896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on evidence for treatment with ranolazine in stable angina.
    Carbone F; Montecucco F; Mach F
    Swiss Med Wkly; 2013; 143():w13874. PubMed ID: 24163124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
    Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J
    Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ranolazine: Drug overview and possible role in primary microvascular angina management.
    Cattaneo M; Porretta AP; Gallino A
    Int J Cardiol; 2015 Feb; 181():376-81. PubMed ID: 25555283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in the management of stable angina.
    Trujillo TC
    J Manag Care Pharm; 2006 Oct; 12(8 Suppl):S10-6. PubMed ID: 23577423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.
    Keating GM
    Drugs; 2013 Jan; 73(1):55-73. PubMed ID: 23329466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resolution of angina pectoris and improvement of the coronary flow reserve after ranolazine treatment in a woman with isolated impaired coronary microcirculation.
    Santoro A; Schiano Lomoriello V; Santoro C; Muscariello R; Galderisi M
    Case Rep Cardiol; 2013; 2013():343027. PubMed ID: 24826280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review.
    Padala SK; Lavelle MP; Sidhu MS; Cabral KP; Morrone D; Boden WE; Toth PP
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):499-510. PubMed ID: 28361599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ranolazine for chronic stable angina.
    Nash DT; Nash SD
    Lancet; 2008 Oct; 372(9646):1335-41. PubMed ID: 18929905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of ranolazine on cardiovascular system.
    Bonadei I; Vizzardi E; Quinzani F; Piovanelli B; Rovetta R; D'Aloia A; Cas LD
    Recent Pat Cardiovasc Drug Discov; 2011 Sep; 6(3):215-21. PubMed ID: 21867482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.